Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) Enterprise Value: 2009-2025

Historic Enterprise Value for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to -$463.1 million.

  • Pediatrix Medical's Enterprise Value fell 11006.89% to -$463.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$463.1 million, marking a year-over-year decrease of 11006.89%. This contributed to the annual value of -$348.5 million for FY2024, which is 9607.3% down from last year.
  • According to the latest figures from Q3 2025, Pediatrix Medical's Enterprise Value is -$463.1 million, which was down 11006.89% from -$348.3 million recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Enterprise Value ranged from a high of -$96.8 million in Q1 2022 and a low of -$486.9 million during Q4 2021
  • In the last 5 years, Pediatrix Medical's Enterprise Value had a median value of -$177.7 million in 2023 and averaged -$237.8 million.
  • As far as peak fluctuations go, Pediatrix Medical's Enterprise Value skyrocketed by 7883.29% in 2022, and later crashed by 16151.19% in 2025.
  • Quarter analysis of 5 years shows Pediatrix Medical's Enterprise Value stood at -$486.9 million in 2021, then surged by 78.83% to -$103.1 million in 2022, then tumbled by 72.46% to -$177.7 million in 2023, then crashed by 96.07% to -$348.5 million in 2024, then tumbled by 32.88% to -$463.1 million in 2025.
  • Its last three reported values are -$463.1 million in Q3 2025, -$348.3 million for Q2 2025, and -$219.2 million during Q1 2025.